All In Biotech

Drug Trial Radar · NCT02223949

Labor Induction and Maternal BMI, Comparison of Different Pre-induction Cervical Ripening Methods

Labor Induction and Maternal BMI: Comparison of Different Pre-induction Cervical Ripening Methods: The Cook Double Balloon Catheter vs PGE1 Tablets in Lean, Overweight, and Obese Women. A Prospective Randomized Study.

Last checked: Nov 19, 2026Latest source record: Aug 22, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 624 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

624

Planned (sponsor's estimate)

Start

Oct 2014

Primary completion

Oct 2016

Study completion Nov 2016

Sponsor

Lead sponsor
Hillel Yaffe Medical CenterGovernment (non-federal)
Sponsor type
Government (non-federal)
First posted
Aug 22, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
Female only, from 18 years, up to 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to investigate whether mechanical cervical ripening (using the Cook double balloon catheter) is superior or inferior to pharmacological agents (PGE1) in overweight and obese women undergoing labor induction.

Conditions

  • Obesity
  • Labor Complications

Interventions

  • Cook double balloon catheterDevice

  • PGE1 tabletDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cesarian section rateTime frame: 24 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Hillel Yaffe Medical Center

    Hadera, Israel

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.